Home539523 • BOM
add
Alkem Laboratories Ltd
Nakaraang pagsara
₹4,723.95
Sakop ng araw
₹4,609.50 - ₹4,752.90
Sakop ng taon
₹4,409.90 - ₹6,440.00
Market cap
553.45B INR
Average na Volume
3.59K
P/E ratio
25.73
Dividend yield
0.91%
Primary exchange
NSE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
(INR) | Dis 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 33.74B | 1.52% |
Gastos sa pagpapatakbo | 14.96B | 8.29% |
Net na kita | 6.26B | 5.19% |
Net profit margin | 18.55 | 3.63% |
Kita sa bawat share | 52.34 | -2.59% |
EBITDA | 7.39B | 4.74% |
Aktuwal na % ng binabayarang buwis | 12.35% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(INR) | Dis 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 22.89B | -36.59% |
Kabuuang asset | — | — |
Kabuuang sagutin | — | — |
Kabuuang equity | 119.10B | — |
Natitirang share | 119.57M | — |
Presyo para makapag-book | 4.91 | — |
Return on assets | — | — |
Return on capital | 12.59% | — |
Cash Flow
Net change in cash
(INR) | Dis 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | 6.26B | 5.19% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Alkem Laboratories Limited is a leading Indian multinational pharmaceutical company headquartered in Mumbai, India. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets a diverse portfolio of pharmaceutical generics, formulations and nutraceuticals across India and global markets.
With over five decades of expertise in the pharmaceutical industry, Alkem's journey began with a vision to transform India's healthcare landscape. Today, the company has established its presence in over 40 countries, operating 19 state-of-the-art manufacturing facilities and driving innovation through a team of 500+ scientists. Backed by a robust portfolio of 800+ brands, Alkem continues to set industry benchmarks in research, development, and manufacturing excellence.
Alkem primarily focuses on developing medications for a wide range of therapeutic areas, including infectious diseases, gastrointestinal disorders, pain management, gynecological conditions, pediatrics, osteoporosis, arthritis, cardiovascular diseases, diabetes, and several other critical health concerns. Wikipedia
Itinatag
1973
Headquarters
Website
Mga Empleyado
17,432